Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation
Bioscience Reports · 29.10.2026
DOI: 10.1042/bsr20260597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 29.10.2026. Verfasst von Nina Heyer-Chauhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: University College London, London, United Kingdom. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Telethon, Alpha-1 Foundation, Medical Research Council.
Abstract (Originalsprache)
Alpha-1 antitrypsin (AAT) is a protease inhibitor, normally found at a high concentration in monomeric form in the circulation from where it protects the lung tissue from proteolytic damage. Pathogenic variants of AAT self-assemble into flexible polymer chains that undergo toxic accumulation in the liver, underlying the development of liver disease; the corresponding deficiency in the circulation results in susceptibility to emphysema. AAT polymers formed by these variants are also detectable in the plasma; this study evaluated the dynamics of circulating monomeric and polymeric AAT after correction of the deficiency state with liver transplantation in four individuals homozygous for the Z deficiency allele (Glu342Lys). The resolution of the pathological circulating AAT phenotype was characterised by analysis of blood samples taken pre- and post-liver transplant using a panel of conformer-specific monoclonal antibodies and a novel ELISA with enhanced sensitivity for AAT polymers. Circulating wild-type M AAT, produced by the allograft liver, increased with a half-timeof 7-39 h, attaining a putative ‘protective’ threshold level 4-55 h post-transplant. Pre-transplant circulating polymer levels ranged from 5-26 μg/mL and declined post-surgery with a half-time of 2-9 h, levels were comparable to those of wild-type M AAT plasma when repeated >200 days post-transplant. The glycosylation profile of liver- and plasma-derived polymers and their progressive disappearance from circulation is consistent with their origin in, and canonical secretion from, the liver. To our knowledge this is the first post-transplant evaluation of the hybrid conformational profile of endogenous and donor tissue-derived AAT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University College London, London, United Kingdom.
- Universita degli Studi di Roma La Sapienza Dipartimento di Biologia e Biotecnologie Charles Darwin, Rome, Italy.
- Royal Free Hospital, London, United Kingdom.
Förderung
- Fondazione Telethon
- Alpha-1 Foundation
- Medical Research Council
Zitieren
APA
Heyer-Chauhan, N., Ronzoni, R., Aldobiyan, I., Miranda, E., Marshall, A., Hurst, J., Irving, J. A., & Lomas, D. A. (2026). Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation. Bioscience Reports. https://doi.org/10.1042/bsr20260597
Vancouver
Heyer-Chauhan N, Ronzoni R, Aldobiyan I, Miranda E, Marshall A, Hurst J, et al. Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation. Bioscience Reports. 2026. doi:10.1042/bsr20260597
BibTeX
@article{HeyerChauhan2026,
author = {Heyer-Chauhan, Nina and Ronzoni, Riccardo and Aldobiyan, Ibrahim and Miranda, Elena and Marshall, Aileen and Hurst, John and Irving, James A and Lomas, David A},
title = {Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation},
journal = {Bioscience Reports},
year = {2026},
doi = {10.1042/bsr20260597}
}
EUVIMED